Stephen R. Byrn

Person

West Lafayette, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyridines for treating injured mammalian nerve tissue
- Patent number 8,729,107
- Issue date May 20, 2014
- Purdue Research Foundation
- Richard B. Borgens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridines for treating injured mammalian nerve tissue
- Patent number 8,097,638
- Issue date Jan 17, 2012
- Purdue Research Foundation
- Richard B. Borgens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridines for treating injured mammalian nerve tissue
- Patent number 7,244,748
- Issue date Jul 17, 2007
- Purdue Research Foundation
- Richard B. Borgens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5...
- Patent number 7,144,915
- Issue date Dec 5, 2006
- Warner-Lambert Company, LLC
- Stephen Robert Byrn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)...
- Patent number 6,605,729
- Issue date Aug 12, 2003
- Warner-Lambert Company
- Stephen Robert Byrn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NADH oxidase assay for neoplasia determination
- Patent number 5,605,810
- Issue date Feb 25, 1997
- Purdue Research Foundation
- D. James Morr e
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PROCESSES FOR PREPARING SOLID STATE FORMS
- Publication number 20240269118
- Publication date Aug 15, 2024
- Varda Space Industries, Inc.
- Adrian RADOCEA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Caffeine Compositions
- Publication number 20240115576
- Publication date Apr 11, 2024
- OYE Therapeutics, Inc
- Brett Dines
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Caffeine Citrate Formulations
- Publication number 20230066204
- Publication date Mar 2, 2023
- OYE Therapeutics, Inc
- Brett Dines
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nilotinib Compositions with Enhanced Solubility
- Publication number 20210260058
- Publication date Aug 26, 2021
- Neoform Biopharmaceutical Limited
- Stephen R. Byrn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE
- Publication number 20110130429
- Publication date Jun 2, 2011
- Purdue Research Foundation
- Richard B. Borgens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihyd...
- Publication number 20080287521
- Publication date Nov 20, 2008
- Pfizer Inc.
- Stephen Robert Byrn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystalline forms of [R-(R*, R*)]-2-(4-fluorophenyl)-beta,delta-dih...
- Publication number 20080214651
- Publication date Sep 4, 2008
- Pfizer Inc.
- Stephen Robert Byrn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE
- Publication number 20080039490
- Publication date Feb 14, 2008
- Purdue Research Foundation
- Richard B. Borgens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Polymorphs of zaleplon and methods for the preparation thereof
- Publication number 20050176735
- Publication date Aug 11, 2005
- Farhan Aslam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyridines for treating injured mammalian nerve tissue
- Publication number 20040171587
- Publication date Sep 2, 2004
- Richard B. Borgens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihy...
- Publication number 20040054193
- Publication date Mar 18, 2004
- Stephen Robert Byrn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polymorphs of zaleplon and methods for the preparation thereof
- Publication number 20020072527
- Publication date Jun 13, 2002
- SSCI, INC.
- Farhan Aslam
- C07 - ORGANIC CHEMISTRY

Stephen R. Byrn

Person

Patents Grantslast 30 patents

Pyridines for treating injured mammalian nerve tissue

Pyridines for treating injured mammalian nerve tissue

Pyridines for treating injured mammalian nerve tissue

Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5...

Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)...

NADH oxidase assay for neoplasia determination

Patents Applicationslast 30 patents

PROCESSES FOR PREPARING SOLID STATE FORMS

Caffeine Compositions

Caffeine Citrate Formulations

Nilotinib Compositions with Enhanced Solubility

PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE

Crystalline Forms Of [R-(R,R)-2-(4-fluorophenyl)-beta,delta-dihyd...

Crystalline forms of [R-(R, R)]-2-(4-fluorophenyl)-beta,delta-dih...

PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE

Polymorphs of zaleplon and methods for the preparation thereof

Pyridines for treating injured mammalian nerve tissue

Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-beta,delta-dihy...

Polymorphs of zaleplon and methods for the preparation thereof

Stephen R. Byrn

Person

Patents Grantslast 30 patents

Pyridines for treating injured mammalian nerve tissue

Pyridines for treating injured mammalian nerve tissue

Pyridines for treating injured mammalian nerve tissue

Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5...

Crystalline forms of &#x0005B;R-(R*,R*)&#x0005D;-2-(4-fluorophenyl)...

NADH oxidase assay for neoplasia determination

Patents Applicationslast 30 patents

PROCESSES FOR PREPARING SOLID STATE FORMS

Caffeine Compositions

Caffeine Citrate Formulations

Nilotinib Compositions with Enhanced Solubility

PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE

Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihyd...

Crystalline forms of [R-(R*, R*)]-2-(4-fluorophenyl)-beta,delta-dih...

PYRIDINES FOR TREATING INJURED MAMMALIAN NERVE TISSUE

Polymorphs of zaleplon and methods for the preparation thereof

Pyridines for treating injured mammalian nerve tissue

Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihy...

Polymorphs of zaleplon and methods for the preparation thereof

Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5...

Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)...

Crystalline Forms Of [R-(R,R)-2-(4-fluorophenyl)-beta,delta-dihyd...

Crystalline forms of [R-(R, R)]-2-(4-fluorophenyl)-beta,delta-dih...

Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-beta,delta-dihy...